Wave Life Sciences Ltd. (FRA:1U5)
Germany
· Delayed Price · Currency is EUR 6.25
+0.40 (6.84%)
Last updated: Dec 5, 2025, 8:10 AM CET
Wave Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 109.23 | 108.3 | 113.31 | 3.65 | 40.96 | 20.08 | Upgrade
|
| Revenue Growth (YoY) | 103.75% | -4.42% | 3005.10% | -91.09% | 104.03% | 25.61% | Upgrade
|
| Cost of Revenue | 174.61 | 159.68 | 130.01 | 115.86 | 121.88 | 130.94 | Upgrade
|
| Gross Profit | -65.38 | -51.38 | -16.7 | -112.21 | -80.91 | -110.87 | Upgrade
|
| Selling, General & Admin | 70.57 | 59.02 | 51.29 | 50.51 | 46.11 | 42.51 | Upgrade
|
| Operating Expenses | 70.57 | 59.02 | 51.29 | 50.51 | 46.11 | 42.51 | Upgrade
|
| Operating Income | -135.95 | -110.4 | -68 | -162.72 | -127.02 | -153.38 | Upgrade
|
| Interest & Investment Income | 11.16 | 10.16 | 7.93 | 1.57 | 0.03 | 0.57 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.84 | 3.23 | 1.88 | 0.01 | 4.54 | 2.06 | Upgrade
|
| Pretax Income | -121.95 | -97.01 | -58.19 | -161.14 | -122.45 | -150.75 | Upgrade
|
| Income Tax Expense | - | - | -0.68 | 0.68 | -0.2 | -0.84 | Upgrade
|
| Net Income | -121.95 | -97.01 | -57.51 | -161.82 | -122.25 | -149.91 | Upgrade
|
| Net Income to Common | -121.95 | -97.01 | -57.51 | -161.82 | -122.25 | -149.91 | Upgrade
|
| Shares Outstanding (Basic) | 164 | 138 | 106 | 79 | 52 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 164 | 138 | 106 | 79 | 52 | 39 | Upgrade
|
| Shares Change (YoY) | 30.63% | 30.33% | 34.55% | 52.16% | 32.12% | 15.83% | Upgrade
|
| EPS (Basic) | -0.74 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | Upgrade
|
| EPS (Diluted) | -0.74 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | Upgrade
|
| Free Cash Flow | -198.17 | -151.96 | -20.55 | -129.14 | -89.55 | -117.32 | Upgrade
|
| Free Cash Flow Per Share | -1.21 | -1.10 | -0.19 | -1.64 | -1.73 | -2.99 | Upgrade
|
| Gross Margin | -59.86% | -47.44% | -14.74% | - | -197.52% | - | Upgrade
|
| Operating Margin | -124.46% | -101.94% | -60.01% | -4459.30% | -310.07% | -763.94% | Upgrade
|
| Profit Margin | -111.64% | -89.57% | -50.76% | -4434.72% | -298.42% | -746.68% | Upgrade
|
| Free Cash Flow Margin | -181.42% | -140.31% | -18.13% | -3539.11% | -218.61% | -584.35% | Upgrade
|
| EBITDA | -132.45 | -106.51 | -63 | -156.15 | -119.53 | -145.26 | Upgrade
|
| EBITDA Margin | -121.25% | -98.34% | -55.60% | - | -291.80% | - | Upgrade
|
| D&A For EBITDA | 3.5 | 3.9 | 5 | 6.57 | 7.48 | 8.11 | Upgrade
|
| EBIT | -135.95 | -110.4 | -68 | -162.72 | -127.02 | -153.38 | Upgrade
|
| EBIT Margin | -124.46% | -101.94% | -60.01% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.